Journey Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	72	107	34	90	-	-
Market Cap Growth	-	213.63%	-62.07%	-	-	-
Enterprise Value	63	97	29	50	10	5
PE Ratio	-27.67	-27.67	-1.15	-2.04	-	-
PS Ratio	0.92	1.35	0.46	1.42	-	-
PB Ratio	3.56	5.24	2.00	2.13	-	-
P/FCF Ratio	13.84	20.35	-2.51	-41.10	-	-
P/OCF Ratio	13.84	20.35	-2.51	-41.10	-	-
EV/Sales Ratio	0.79	1.22	0.39	0.79	0.22	0.16
EV/EBITDA Ratio	32.69	50.44	-1.23	-1.51	1.24	1.03
EV/EBIT Ratio	-50.10	-50.10	-1.04	-1.40	1.25	1.04
EV/FCF Ratio	11.98	18.49	-2.11	-22.74	1.91	0.61
Debt / Equity Ratio	0.87	0.87	1.57	0.22	1.75	3.74
Debt / EBITDA Ratio	9.23	9.23	-1.15	-0.28	2.27	1.92
Debt / FCF Ratio	3.38	3.38	-1.97	-4.15	3.52	1.14
Quick Ratio	1.02	1.02	0.90	1.40	1.15	1.14
Current Ratio	1.35	1.35	1.16	1.64	1.26	1.21
Asset Turnover	1.03	1.03	0.66	0.85	1.04	-
Interest Coverage	-1.14	-1.14	-13.64	-5.02	11.25	20.62
Return on Equity (ROE)	-34.10%	-34.10%	-99.30%	-168.10%	81.00%	-
Return on Assets (ROA)	-5.00%	-5.00%	-26.50%	-59.00%	12.30%	-
Return on Capital (ROIC)	-5.44%	-5.44%	-63.11%	-68.27%	20.45%	29.20%
Earnings Yield	-5.31%	-3.61%	-87.16%	-49.08%	-	-
FCF Yield	7.23%	4.92%	-39.81%	-2.43%	-	-
Buyback Yield / Dilution	-4.00%	-4.00%	-72.05%	5.96%	-7.55%	-
Total Shareholder Return	-4.00%	-4.00%	-72.05%	5.96%	-7.55%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).